Palvella Therapeutics, Inc (PVLA)
Who owns Palvella Therapeutics, Inc (PVLA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 66.8% of the shares are freely tradable; institutional investors hold 96.4%.
Ownership Structure
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Suvretta Capital Management, LLC | 8.04 | 1,153,496 | +29.3 | 03/31/2026 |
| First Light Asset Management, LLC | 6.84 | 980,758 | +38.3 | 03/31/2026 |
| Bvf Inc | 6.70 | 960,989 | +9.3 | 03/31/2026 |
| Frazier Life Sciences Management, L.P. | 6.15 | 882,400 | +22.1 | 03/31/2026 |
| BlackRock Inc | 4.79 | 686,853 | +22.9 | 03/31/2026 |
| Jennison Associates LLC | 4.47 | 640,611 | +65.3 | 03/31/2026 |
| Vanguard Group Inc | 3.91 | 560,616 | +13.3 | 12/31/2025 |
| Vanguard Capital Management, LLC | 3.33 | 477,294 | +0.0 | 03/31/2026 |
| State Street Corp | 3.20 | 458,999 | +9.2 | 03/31/2026 |
| Federated Hermes Inc | 3.02 | 433,015 | +17.7 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 15. Jul 2026 | Goin Kathleen | Chief Operating Officer | Sell | 1,911 | 150.25 | 287,133 |
| 15. Jul 2026 | Goin Kathleen | Chief Operating Officer | Sell | 1,029 | 149.27 | 153,595 |
| 15. Jul 2026 | Goin Kathleen | Chief Operating Officer | Sell | 840 | 148.40 | 124,658 |
| 15. Jul 2026 | Goin Kathleen | Chief Operating Officer | Sell | 522 | 147.14 | 76,805 |
| 15. Jul 2026 | Goin Kathleen | Chief Operating Officer | Other | 2,148 | 9.08 | 19,504 |
| 15. Jul 2026 | Goin Kathleen | Chief Operating Officer | Other | 2,154 | 7.14 | 15,380 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.